Mersana Therapeutics, Inc. Accounts Payable
Mersana Therapeutics, Inc. had Accounts Payable of $2.39 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-14
- 2025-09-30: Accounts Payable, Current $2.39M.
- 2025-06-30: Accounts Payable, Current $2.92M.
- 2025-03-31: Accounts Payable, Current $4.37M.
- 2024-12-31: Accounts Payable, Current $4.33M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $2.39M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.92M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $4.37M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $4.33M 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $2.03M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $3.01M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.09M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $7.32M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $12.95M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $16.92M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $18.16M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $13.95M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $13.73M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $8.16M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $9.78M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $12.32M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $5.87M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $10.65M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $11.74M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $8.34M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $4.53M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $7.16M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.60M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $7.30M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $7.30M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $6.52M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $6.96M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.73M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $6.73M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $4.16M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.52M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.07M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $3.21M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.86M 10-Q · filed 2017-08-11 | |
| 2016-12-31 | $2.07M 10-K · filed 2018-03-28 | $2.07M 10-Q · filed 2017-08-11 |